• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Siemens CEO Kaeser: We’ll keep a majority stake in Healthineers after split

Siemens CEO Kaeser: We’ll keep a majority stake in Healthineers after split

March 29, 2017 By Brad Perriello

Siemens HealthineersSiemens (NYSE:SI) will retain a majority stake in its Healthineers business after its planned initial public offering or spinout, CEO Joe Kaeser told a Swiss newspaper this week.

The healthcare business, which Siemens rebranded last year to worldwide scorn, is the company’s most profitable unit with an estimated enterprise value of roughly €36 billion to €37 billion ($39 billion to $40 billion). The German industrial conglomerate is mulling the idea of an IPO, Kaeser said last month.

“We will keep the majority. It is 1 of our most attractive businesses and will be the 3rd pillar alongside renewable energy and the industrial Siemens,” Kaeser told the Finanz und Wirtschaft newspaper.

But the flotation might not take place on a U.S. exchange now that the Trump administration is in power, he added, citing Frankfurt and Hong Kong as potential alternatives.

Healthineers last month repored boosting its fiscal 1st-quarter profits by nearly 15% despite flat sales, as Siemens overall shares surged to a 17-year high on its overall profit increase of nearly 25%.

The healthcare division reported profits of €620 million ($668.8 million) on sales of €3.28 billion ($3.54 billion) for the 3 months ended Dec. 31, for bottom-line growth of 14.6% on a -0.2% sales decline.

Quarterly profits for the Siemens overall were €1.94 billion ($2.09 billion), or €2.32 ($2.50) per share, on sales of €19.12 billion ($20.62 billion). Analysts were looking for earnings per share of €1.66 on sales of €19.56 billion.

Siemens raised its earnings outlook for fiscal 2017, saying it now expects to log EPS of €7.20 to €7.70, up from prior guidance for €6.80 to €7.20.

Material from Reuters was used in this report.

Filed Under: Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Siemens

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy